Bio Nexa's Technology: Where Semiconductors Meet Human Biology
The BioNexa Biosensor Platform merges semiconductor microfabrication, biocompatible nanochemistry, and AI-driven analytics into a single, wearable device. Unlike traditional wearables that track heart rate or motion, our sensor directly measures molecular biomarkers—proteins, metabolites, and ions offering laboratory-grade insights from anywhere in the world.
By integrating edge computing and secure cloud infrastructure, each chip processes and transmits data with unmatched accuracy, privacy, and speed. This is not incremental innovation; it’s a new class of real-time molecular intelligence designed for the next era of clinical research.
Built on domestic semiconductor manufacturing, our platform advances U.S. technological independence under the CHIPS and Science Act—bridging the gap between human health and hardware innovation.
Revolutionizing Clinical Monitoring Through Silicon-Based Biosensor Technology
At BioNexa, we are redefining how clinical trials and chronic-care studies collect and interpret patient data. Our breakthrough silicon biosensor platform continuously monitors key biomarkers in real time, empowering researchers and clinicians to make faster, data-driven decisions.
Our Phase I R&D effort, focuses on:
Design
Designing and fabricating a silicon-based sensor array capable of multi-analyte detection.
Developing functional surface coatings that ensure biocompatibility and molecular specificity.
AI Integration
Integrating edge AI algorithms for real-time signal processing and anomaly detection.
Validations
Validating the system in pre-clinical and pilot clinical environments.
These efforts lay the foundation for scalable, U.S.-based manufacturing of biosensor devices that transform how medical data is collected and applied.
Clinical
Impact
Today, 60 % of adverse events in clinical trials occur between scheduled site visits. BioNexa’s continuous-monitoring platform eliminates these blind spots by delivering minute-to-minute biochemical data to investigators.
Bio Nexa's Mission:
Earlier intervention, safer trials, and more personalized treatment pathways.
This technology will reduce trial timelines, expand patient diversity through decentralized participation, and drive measurable improvements in research outcomes across cardiometabolic, oncology, and neurodegenerative studies.
